PAVmed (PAVM) Enterprise Value Growth (3y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.71% |
| Sep 30, 2025 | 28.84% |
| Jun 30, 2025 | 33.13% |
| Mar 31, 2025 | 41.79% |
| Dec 31, 2024 | 53.40% |
| Jun 30, 2024 | 38.83% |
| Mar 31, 2024 | 34.74% |
| Dec 31, 2023 | 36.05% |
| Sep 30, 2023 | 28.07% |
| Jun 30, 2023 | 8.87% |
| Mar 31, 2023 | -18.12% |
| Dec 31, 2022 | -39.59% |
| Sep 30, 2022 | -100.42% |
| Jun 30, 2022 | -84.75% |
| Mar 31, 2022 | -118.29% |
| Dec 31, 2021 | -92.18% |
| Sep 30, 2021 | -58.24% |
| Jun 30, 2021 | -57.89% |
| Mar 31, 2021 | -140.95% |
| Dec 31, 2020 | -133.83% |
| Sep 30, 2020 | -48.34% |
| Jun 30, 2020 | -370.85% |
| Mar 31, 2020 | -122.40% |
| Dec 31, 2019 | -129.00% |
| Sep 30, 2019 | -37.18% |
| Jun 30, 2019 | -33.86% |
| Mar 31, 2019 | -165.47% |
| Dec 31, 2018 | -121.90% |
| Sep 30, 2018 | -87.52% |
| Jun 30, 2018 | -178.03% |